Synopsys Beats Q1 Earnings Estimates and Announces $2 Billion Share Buyback Program

Synopsys, Inc. (SNPS) reported strong financial results for the first quarter of fiscal year 2026, with revenue reaching $2.409 billion. This performance hit the high end of the company's prior guidance, reflecting robust execution across its business segments. Non-GAAP earnings per diluted share came in at $3.77, successfully exceeding analyst expectations. In a significant move to return value to shareholders, the board of directors approved a new stock repurchase program authorized for up to $2.0 billion. This buyback reflects management's confidence in the company's long-term cash flow generation and growth prospects. Meanwhile, Kewaunee Scientific (KEQU) announced it will release its third-quarter results on March 11, 2026.